ASLAN Pharmaceuticals Limited (ASLN)
July 26, 2024 - ASLAN Pharmaceuticals Limited was delisted.
0.600
-0.100 (-14.27%)
Inactive · Last trade price
on Jul 18, 2024
ASLAN Pharmaceuticals Stock Forecast
ASLN's stock price has decreased by -97.15% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ASLN stock had an average target of 90.67, with a low estimate of 72 and a high estimate of 120.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 3, 2024.
Analyst Ratings
The average analyst rating for ASLN stock from 3 stock analysts was "Strong Buy". This means that analysts believed this stock was likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +11,900.00% | May 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +11,900.00% | Apr 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +11,900.00% | Apr 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $136 → $72 | Strong Buy | Maintains | $136 → $72 | +11,900.00% | Mar 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $120 → $80 | Buy | Reiterates | $120 → $80 | +13,233.33% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
n/a
from 12.00M
Revenue Next Year
n/a
EPS This Year
-3.41
from -22.00
EPS Next Year
-2.40
from -3.41
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | n/a | n/a |
| Avg | n/a | n/a |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -3.51 | -2.47 |
| Avg | -3.41 | -2.40 |
| Low | -3.27 | -2.30 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.